Why is 1/2 normal saline (half normal saline) used in the treatment of Hyperosmolar Hyperglycemic State (HHS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Use of Half Normal Saline (0.45% NaCl) in Hyperosmolar Hyperglycemic State (HHS) Treatment

Half normal saline (0.45% NaCl) is used in HHS treatment after initial resuscitation with normal saline because it helps correct the hypertonic dehydration while avoiding rapid changes in serum osmolality that could lead to cerebral edema. 1

Fluid Therapy Approach in HHS

Initial Fluid Therapy

  • Begin with isotonic saline (0.9% NaCl) at 15-20 ml/kg/h during the first hour to expand intravascular volume and restore renal perfusion 1
  • Normal saline is preferred initially to stabilize hemodynamics and ensure adequate perfusion of vital organs 2
  • HHS patients typically have more severe dehydration than DKA patients, with average total water deficits of approximately 9 liters versus 6 liters in DKA 1

Transition to Half Normal Saline

  • After hemodynamic stabilization, transition to 0.45% NaCl at 4-14 ml/kg/h if the corrected serum sodium is normal or elevated 1
  • Continue with 0.9% NaCl if corrected serum sodium is low 1
  • The rationale for using 0.45% NaCl is based on the pathophysiology of HHS: 2, 3
    • In HHS, water losses exceed sodium losses, resulting in hypertonic dehydration
    • Hypotonic fluids are ultimately required to correct this imbalance

Electrolyte Management

  • Once renal function is assured, add 20-30 mEq/L potassium (2/3 KCl and 1/3 KPO4) to the infusion 1
  • Monitor electrolytes closely as HHS patients have significant depletion of potassium and other electrolytes 2

Monitoring and Safety Considerations

Osmolality Management

  • The induced change in serum osmolality should not exceed 3 mOsm/kg/h to prevent neurological complications 1
  • Careful monitoring of serum osmolality is essential, especially in patients with renal or cardiac compromise 4

Glucose Management

  • When blood glucose approaches 250-300 mg/dl, add 5% dextrose to the IV fluids and reduce insulin infusion rate 2, 3
  • Insulin should be administered at lower doses in HHS compared to DKA (initial bolus of 0.15 U/kg followed by 0.1 U/kg/hour) 5

Neurological Monitoring

  • Monitor mental status frequently to detect changes that might indicate iatrogenic complications like cerebral edema 1, 6
  • Encephalopathy is common in HHS and requires careful management of fluid therapy 6

Important Considerations and Pitfalls

  • Fluid replacement should correct estimated deficits within the first 24 hours 1, 4
  • Avoid excessive fluid administration in patients with cardiac or renal compromise to prevent fluid overload 4
  • Failure to correct serum sodium for hyperglycemia may lead to inappropriate fluid selection 4
  • Remember that HHS patients typically require more aggressive fluid resuscitation than DKA patients due to more profound dehydration 6, 3
  • Careful monitoring of potassium levels is crucial as insulin therapy can precipitate dangerous hypokalemia 4

Special Populations

  • In pediatric patients (<20 years), initial fluid therapy should be with isotonic saline (0.9% NaCl) at 10-20 ml/kg/h for the first hour 1
  • Initial reexpansion in pediatric patients should not exceed 50 ml/kg over the first 4 hours to reduce risk of cerebral edema 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyperglycemic hyperosmolar nonketotic syndrome.

Indian journal of pediatrics, 2006

Guideline

Initial Fluid Replacement for Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperosmolar hyperglycemic state.

American family physician, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.